3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
67
Colonic Neoplasms
31
Rectal Neoplasms
30
Pancreatic Neoplasms
18
Stomach Neoplasms
16
Neoplasm Metastasis
14
Carcinoma, Hepatocellular
14
Esophageal Neoplasms
6
Leukemia
5
Neoplasms
4
Lymphoma
4
Liver Neoplasms
3
Gastrointestinal Neoplasms
3
Cholangiocarcinoma
3
Carcinoma
3
Adenocarcinoma Of Esophagus
3
Solid Tumors
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neutropenia
2
Leukemia, Biphenotypic, Acute
2
Gallbladder Neoplasms
2
Digestive System Neoplasms
2
Colorectal Cancer Metastatic
2
Carcinoma, Squamous Cell
2
Breast Neoplasms
2
Biliary Tract Neoplasms
2
Bile Duct Neoplasms
2
mCRC
1
Unresectable Sinonasal Tumors
1
Thymoma
1
Interventions
Oxaliplatin
1
Leucovorin
1
Irinotecan
1
Gemcitabine
1
Fluorouracil
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Metastatic Pancreatic Adenocarcinoma
×
Leucovorin
×
Clear all
NCT01729481
2017-07-19
ML22774
Ludwig-Maximilians - University of Munich
Phase 2
Unknown
150 enrolled